Effects of prospective, randomized cholesterol-lowering dietary intervention and apolipoprotein E phenotype on serum lipoprotein(a) concentrations of infants aged 7-24 mo

American Journal of Clinical Nutrition

Volumn 63, Issue 3, 1996, Pages 386-391

  Routi, Taina ^a   Rönnemaa, Tapani ^b   Salo, Pia ^b   Seppänen, Ritva ^b   Marniemi, Jukka ^b   Viikari, Jorma ^b   Ehnholm, Christian ^b   Simell, Olli ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE

Author keywords

apolipoprotein E; children; dietary intervention; Lipoprotein(a); prospective trial

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; FATTY ACID; LIPOPROTEIN A;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAT INTAKE; FOOD COMPOSITION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PHENOTYPE; PRESCHOOL CHILD;

EID: 0029912148     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/63.3.386     Document Type: Article

References (44)

1. Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W. The relation of lipoprotein(a) concentrations and apolipoprotein(a) phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993;13:1558-66.
2. Schaefer EJ, Lamon-Fava S, Jenner JL, et al. Lipoprotein(a) levels and risk of coronary heart disease in men. JAMA 1994;271:999-1003.
3. Bostom AG, Gagnon DR, Cupples LA, et al. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 1994;90:1688-95.
4. Dahlén GH, Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994;108:111-26.
5. Karádi I, Kostner GM, Gries A, Nimpf J, Romics L, Malle E. Lipoprotein(a) and plasminogen are immunochemically related. Biochim Biophys Acta 1988;960:91-7.
6. Howard GC, Pizzo SV. Biology of disease. Lipoprotein(a) and its role in atherothrombotic disease. Lab Invest 1993;69:373-86.
7. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992;90:52-60.
8. Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J Clin Invest 1994;93:2526-34.
9. Routi T, The STRIP Baby Study Group. Correlation of Lp(a) concentration in children at 24 months of age to their parents' Lp(a) values, and association of Lp(a) levels to family history of coronary artery disease. Eur Heart J 1994;15(suppl):9(abstr).
10. Nestel P, Noakes M, Belling B, et al. Plasma lipoprotein lipid and Lp(a) changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 1992;33:1029-36.
11. Mensink RP, Zock PL, Katan MB, Hornstra G. Effect of dietary cis and trans fatty acids on serum lipoprotein(a) levels in humans. J Lipid Res 1992;33:1493-501.
12. Tholstrup T, Vessby B, Sandstrom B. Effect of individual dietary saturated fatty acids on plasma lipoprotein(a) levels in healthy young men. Atherosclerosis 1994;109(suppl):279 (abstr).
13. Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 1989;226:271-6.
14. Shewmon DA, Stock JL, Rosen CJ, et al. Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women. Arterioscler Thromb 1994,14:1586-93.
15. Berglund L. Diet and drug therapy for lipoprotein(a), Curr Opin Lipidol 1995;6:48-56.
16. Rönnemaa T, Routi T, Lapinleimu H, et al. Serum lipoprotein(a) concentrations in breast-fed and formula-fed infants. The STRIP baby project. Nutr Metab Cardiovasc Dis 1994;4:188-91.
17. Routi T, Rönnemaa T, Lapinleimu H, et al. Effect of weaning on serum Lp(a) concentration. Pediatr Res 1995;38:522-7.
18. Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984; 25:1277-94.
19. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
20. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 1977;269: 604-7.
21. Ehnholm C, Lukka M, Kuusi T, Nikkila E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-35.
22. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113:433-40.
23. Zannis VI, Just PW, Breslow JL. Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 1981;33:11-24.
24. Sing CF, Davignon J. Role of apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985;37:268-85.
25. Lehtimaki T, Moilanen T, Viikari J, et al. Apolipoprotein E phenotype in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990;31:487-95.
26. De Knijff P, Kaptein A, Boomsma D, Princen HMG, Frants RR, Havekes LM. Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a). Atherosclerosis 1991;90:169-74.
27. Rauramaa R, Väisänen S, Rankinen T, Hämäläinen E, Hakulinen P, Ryynänen M. Serum apolipoprotein(a) levels and apolipoprotein E polymorphism in middle-aged men. Atherosclerosis 1994;109(suppl): 263-4(abstr).
28. Tiret L, de Knijff P, Menzel H-J, Ehnhom C, Nicaud V, Havekes LM. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. Arterioscler Thromb 1994;14:1617-24.
29. Lapinleimu H, Viikari J, Jokinen E, et al. A prospective randomised trial in 1062 infants of a reduced saturated fat and cholesterol diet. Lancet 1995;341:471-6.
30. Räsänen L, Ylönen K. Food consumption and nutrient intake of one-to two-year-old Finnish children. Acta Paediatr 1992;81:7-11.
31. März W, Siekmeier R, Gross E, Gross W. Determination of lipoprotein(a): enzyme immunoassay and immunoradiometric assay compared. Clin Chim Acta 1993;214:153-63.
32. Siedet J, Hägele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-80.
33. Kostner GM. Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 1976;22:695.
34. Lapinleimu H, Jokinen E, Myyrinmaa A, et al. Individualized dietary counselling of families: serum cholesterol concentration and growth of children aged 7-13 months. Acta Paediatr 1994;83:383-8.
35. Sorva R, Tolppanen E-M, Perheentupa J. Variation of growth in length and weight of children. I Years 1 and 2. Acta Paediatr 1990;79:490-7.
36. Taimela S, Viikari JSA, Porkka KVK, Dahlén GH. Lipoprotein(a) levels in children and young adults: the influence of physical activity. The Cardiovascular Risk in Young Finns Study. Acta Paediatr 1994; 83:1258-63.
37. Brown SA, Morrisett JD, Patsch JR, Reeves R, Gotto AM Jr, Patsch W. Influence of short term dietary cholesterol and fat on human plasma Lp(a) and LDL levels. J Lipid Res 1991;32:1281-9.
38. Li KM, Wilcken DEL, Dudman NPB. Effect of serum lipoprotein(a) on estimation of low-density lipoprotein cholesterol by the Friedewald formula. Clin Chem 1994;40:571-3.
39. Nydahl MC, Gustafsson I-B, Vessby B. Lipid-lowering diets enriched with monounsaturated or polyunsaturated fatty acids but low in saturated fatty acids have similar effects on serum lipid concentrations in hyperlipidemic patients. Am J Clin Nutr 1994;59:115-22.
40. Horita K, Eto M, Saito M, et al. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels. Artery 1993;20:324-36.
41. White AL, Rainwater DL, Lanford RE. Intracellular maturation of apolipoprotein(a) and assembly of lipoprotein(a) in primary baboon hepatocytes. J Lipid Res 1993;34:509-17.
42. 4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc Natl Acad Sci U S A 1993,90:11643-7.
43. Utermann G, Hoppichler F, Dieplinger H, Seed M, Thompson G, Boerwinkle E. Defects in the low density lipoprotein gene affect lipoprotein(a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci U S A 1989;86:4171-4.
44. Gylling H, Miettinen TA. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J Lipid Res 1992;33: 1361-71.